Cargando…
Mechanisms by Which the MBD2/miR-301a-5p/CXCL12/CXCR4 Pathway Regulates Acute Exacerbations of Chronic Obstructive Pulmonary Disease
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by irreversible expiratory airflow obstruction, and its chronic course is worsened by recurrent acute exacerbations. Our previous microarray assay identified microRNA (miR)-301a-5p as being associated with progression of acute...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585268/ https://www.ncbi.nlm.nih.gov/pubmed/33116473 http://dx.doi.org/10.2147/COPD.S261522 |
_version_ | 1783599752893431808 |
---|---|
author | Shen, Wen Weng, Zhiyin Fan, Minjuan Wang, Shukun Wang, Ruili Zhang, Yang Tian, Hong Wang, Xi Wu, Xin Yang, Xiaolei Wei, Wei Yuan, Kaifen |
author_facet | Shen, Wen Weng, Zhiyin Fan, Minjuan Wang, Shukun Wang, Ruili Zhang, Yang Tian, Hong Wang, Xi Wu, Xin Yang, Xiaolei Wei, Wei Yuan, Kaifen |
author_sort | Shen, Wen |
collection | PubMed |
description | BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by irreversible expiratory airflow obstruction, and its chronic course is worsened by recurrent acute exacerbations. Our previous microarray assay identified microRNA (miR)-301a-5p as being associated with progression of acute exacerbation of COPD (AE-COPD); however, the mechanism underlying COPD pathogenesis remains unknown. METHODS: Samples of serum and peripheral blood mononuclear cells (PBMCs) were isolated from healthy control subjects and patients with stable COPD (R-COPD) or with an acute exacerbation of COPD (AE-COPD). Human HULEC-5a and human bronchial epithelial (HBE) cells were transfected with methyl-CpG-binding domain protein 2 (MBD2), sh-MBD2, miR-301a-5p mimics or an inhibitor, and then stimulated with cigarette smoke extract (CSE). Conditioned medium co-culture assays were performed by adding the supernatant of medium derived from HULEC-5a cells transfected with miR-301a-5p mimics or inhibitor into wells containing si-c-x-c motif chemokine receptor 4 (CXCR4)-transfected-lung fibroblasts or human leukemic THP-1 cell line macrophages. Transwell assays were performed to analyze cell migration. RESULTS: Our analysis of clinical samples showed that decreased miR-301a-5p levels in patients with AE-COPD were positively correlated with levels of MBD2 expression, but negatively correlated with levels of chemokine ligand C-X-C motif chemokine ligand 12 (CXCL12) expression. MBD2 overexpression significantly promoted miR-301a-5p production, but suppressed CXCL12 production in HULEC-5a and HBE cells. CXCL12 was confirmed to be a direct target of miR-301a-5p. CXCR4 knockdown significantly enhanced the suppressive effect of miR-301a-5p mimics and attenuated the promotional effects of the miR-301a-5p inhibitor on the migration of circulating fibroblasts and macrophages, as well as the expression levels of phospho-mitogen-activated protein kinase (p-MEK) and phospho-protein kinase B (p-AKT). CONCLUSION: In summary, the MBD2/miR-301a-5p/CXCL12/CXCR4 pathway was shown to affect the migration of lung fibroblasts and monocyte-derived macrophages, which may play an important role during COPD exacerbations. |
format | Online Article Text |
id | pubmed-7585268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75852682020-10-27 Mechanisms by Which the MBD2/miR-301a-5p/CXCL12/CXCR4 Pathway Regulates Acute Exacerbations of Chronic Obstructive Pulmonary Disease Shen, Wen Weng, Zhiyin Fan, Minjuan Wang, Shukun Wang, Ruili Zhang, Yang Tian, Hong Wang, Xi Wu, Xin Yang, Xiaolei Wei, Wei Yuan, Kaifen Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by irreversible expiratory airflow obstruction, and its chronic course is worsened by recurrent acute exacerbations. Our previous microarray assay identified microRNA (miR)-301a-5p as being associated with progression of acute exacerbation of COPD (AE-COPD); however, the mechanism underlying COPD pathogenesis remains unknown. METHODS: Samples of serum and peripheral blood mononuclear cells (PBMCs) were isolated from healthy control subjects and patients with stable COPD (R-COPD) or with an acute exacerbation of COPD (AE-COPD). Human HULEC-5a and human bronchial epithelial (HBE) cells were transfected with methyl-CpG-binding domain protein 2 (MBD2), sh-MBD2, miR-301a-5p mimics or an inhibitor, and then stimulated with cigarette smoke extract (CSE). Conditioned medium co-culture assays were performed by adding the supernatant of medium derived from HULEC-5a cells transfected with miR-301a-5p mimics or inhibitor into wells containing si-c-x-c motif chemokine receptor 4 (CXCR4)-transfected-lung fibroblasts or human leukemic THP-1 cell line macrophages. Transwell assays were performed to analyze cell migration. RESULTS: Our analysis of clinical samples showed that decreased miR-301a-5p levels in patients with AE-COPD were positively correlated with levels of MBD2 expression, but negatively correlated with levels of chemokine ligand C-X-C motif chemokine ligand 12 (CXCL12) expression. MBD2 overexpression significantly promoted miR-301a-5p production, but suppressed CXCL12 production in HULEC-5a and HBE cells. CXCL12 was confirmed to be a direct target of miR-301a-5p. CXCR4 knockdown significantly enhanced the suppressive effect of miR-301a-5p mimics and attenuated the promotional effects of the miR-301a-5p inhibitor on the migration of circulating fibroblasts and macrophages, as well as the expression levels of phospho-mitogen-activated protein kinase (p-MEK) and phospho-protein kinase B (p-AKT). CONCLUSION: In summary, the MBD2/miR-301a-5p/CXCL12/CXCR4 pathway was shown to affect the migration of lung fibroblasts and monocyte-derived macrophages, which may play an important role during COPD exacerbations. Dove 2020-10-19 /pmc/articles/PMC7585268/ /pubmed/33116473 http://dx.doi.org/10.2147/COPD.S261522 Text en © 2020 Shen et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Shen, Wen Weng, Zhiyin Fan, Minjuan Wang, Shukun Wang, Ruili Zhang, Yang Tian, Hong Wang, Xi Wu, Xin Yang, Xiaolei Wei, Wei Yuan, Kaifen Mechanisms by Which the MBD2/miR-301a-5p/CXCL12/CXCR4 Pathway Regulates Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title | Mechanisms by Which the MBD2/miR-301a-5p/CXCL12/CXCR4 Pathway Regulates Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title_full | Mechanisms by Which the MBD2/miR-301a-5p/CXCL12/CXCR4 Pathway Regulates Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title_fullStr | Mechanisms by Which the MBD2/miR-301a-5p/CXCL12/CXCR4 Pathway Regulates Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title_full_unstemmed | Mechanisms by Which the MBD2/miR-301a-5p/CXCL12/CXCR4 Pathway Regulates Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title_short | Mechanisms by Which the MBD2/miR-301a-5p/CXCL12/CXCR4 Pathway Regulates Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
title_sort | mechanisms by which the mbd2/mir-301a-5p/cxcl12/cxcr4 pathway regulates acute exacerbations of chronic obstructive pulmonary disease |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585268/ https://www.ncbi.nlm.nih.gov/pubmed/33116473 http://dx.doi.org/10.2147/COPD.S261522 |
work_keys_str_mv | AT shenwen mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT wengzhiyin mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT fanminjuan mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT wangshukun mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT wangruili mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT zhangyang mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT tianhong mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT wangxi mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT wuxin mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT yangxiaolei mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT weiwei mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease AT yuankaifen mechanismsbywhichthembd2mir301a5pcxcl12cxcr4pathwayregulatesacuteexacerbationsofchronicobstructivepulmonarydisease |